Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hughes, A. J.
Right arrow Articles by Lees, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hughes, A. J.
Right arrow Articles by Lees, A. J.
NEUROLOGY 1992;42:1142
© 1992 American Academy of Neurology

What features improve the accuracy of clinical diagnosis in Parkinson's disease

A clinicopathologic study

Andrew J. Hughes, FRACP, Yoav Ben-Shlomo, MRCP, Susan E. Daniel, MRCPath and Andrew J. Lees, FRCP

Department of Neurology, The Middlesex Hospital, London, UK.(Drs. Hughes and Lees)
Parkinson's Disease Society Brain Bank, Institute of Neurology, London, UK. (Drs. Hughes, Daniel, and Lees)
Department of Epidemiology and Public Health, University College London, London, UK. (Dr. Ben-Shlomo)

Many authorities have drawn attention to the difficulties in clinically distinguishing Parkinson's disease (PD) from other parkinsonian syndromes. We assessed the clinical features of 100 patients diagnosed prospectively by a group of consultant neurologists as having idiopathic PD according to their pathologic findings. Seventy-six percent of these cases were confirmed to have PD. By using selected criteria (asymmetrical onset, no atypical features, and no possible etiology for another parkinsonian syndrome) the proportion of true PD cases identified was increased to 93%, but 32% of pathologically confirmed cases were rejected on this basis. These observations suggest that studies based on consultant diagnosis of PD, using standard diagnostic criteria, will include cases other than PD, thus distorting results from clinical trials and epidemiologic studies. The strict use of additional criteria can reduce misdiagnosis but at the cost of excluding genuine PD cases.

Address correspondence and reprint requests to Dr. Andrew J. Lees, Department of Neurology, The Middlesex Hospital, Mortimer Street, London WIN 8AA, UK.

Dr. Hughes and Dr. Daniel are funded by the Parkinson's Disease Society, UK. Dr. Ben-Shlomo is a Wellcome research fellow in Clinical Epidemiology.

Received August 9, 1991. Accepted for publication in final form November 5, 1991.




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
R Caslake, J N Moore, J C Gordon, C E Harris, and C Counsell
Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism
J. Neurol. Neurosurg. Psychiatry, November 1, 2008; 79(11): 1202 - 1207.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. Ishihara-Paul, M. M. Hulihan, J. Kachergus, R. Upmanyu, L. Warren, R. Amouri, R. Elango, R. K. Prinjha, A. Soto, M. Kefi, et al.
PINK1 mutations and parkinsonism
Neurology, September 16, 2008; 71(12): 896 - 902.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
W. J. Weiner
There Is No Parkinson Disease
Arch Neurol, June 1, 2008; 65(6): 705 - 708.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. D. Wahner, J. M. Bronstein, Y. M. Bordelon, and B. Ritz
Statin use and the risk of Parkinson disease
Neurology, April 15, 2008; 70(16_Part_2): 1418 - 1422.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J Jankovic
Parkinson's disease: clinical features and diagnosis
J. Neurol. Neurosurg. Psychiatry, April 1, 2008; 79(4): 368 - 376.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Bogdanov, W. R. Matson, L. Wang, T. Matson, R. Saunders-Pullman, S. S. Bressman, and M. F. Beal
Metabolomic profiling to develop blood biomarkers for Parkinson's disease
Brain, February 1, 2008; 131(2): 389 - 396.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. D. Wahner, J. M. Bronstein, Y. M. Bordelon, and B. Ritz
Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease
Neurology, November 6, 2007; 69(19): 1836 - 1842.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J.-M. Kim, S. Hong, G. P. Kim, Y. J. Choi, Y. K. Kim, S. S. Park, S. E. Kim, and B. S. Jeon
Importance of Low-Range CAG Expansion and CAA Interruption in SCA2 Parkinsonism
Arch Neurol, October 1, 2007; 64(10): 1510 - 1518.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. D. Wahner, J. S. Sinsheimer, Jeff. M. Bronstein, and B. Ritz
Inflammatory Cytokine Gene Polymorphisms and Increased Risk of Parkinson Disease
Arch Neurol, June 1, 2007; 64(6): 836 - 840.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
L. Ishihara, L. Warren, R. Gibson, R. Amouri, S. Lesage, A. Durr, M. Tazir, Z. K. Wszolek, R. J. Uitti, W. C. Nichols, et al.
Clinical Features of Parkinson Disease Patients With Homozygous Leucine-Rich Repeat Kinase 2 G2019S Mutations.
Arch Neurol, September 1, 2006; 63(9): 1250 - 1254.
[Abstract] [Full Text] [PDF]


Home page
PNHome page
K. S M Taylor and C. Counsell
Is it Parkinson's disease, and if not, what is it?
Practical Neurology, June 1, 2006; 6(3): 154 - 165.
[Full Text] [PDF]


Home page
NeurologyHome page
O. Suchowersky, S. Reich, J. Perlmutter, T. Zesiewicz, G. Gronseth, and W. J. Weiner
Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Neurology, April 11, 2006; 66(7): 968 - 975.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D R Williams, H C Watt, and A J Lees
Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study
J. Neurol. Neurosurg. Psychiatry, April 1, 2006; 77(4): 468 - 473.
[Abstract] [Full Text] [PDF]


Home page
JSLHRHome page
J. N. Caviness, J. M. Liss, C. Adler, and V. Evidente
Analysis of high-frequency electroencephalographic-electromyographic coherence elicited by speech and oral nonspeech tasks in Parkinson's disease.
J Speech Lang Hear Res, April 1, 2006; 49(2): 424 - 438.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. E. Glatt, A. D. Wahner, D. J. White, A. Ruiz-Linares, and B. Ritz
Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women
Hum. Mol. Genet., January 15, 2006; 15(2): 299 - 305.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. Oishi, F. Udaka, M. Kameyama, N. Sawamoto, K. Hashikawa, and H. Fukuyama
Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations
Neurology, December 13, 2005; 65(11): 1708 - 1715.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
W.-H. Lee, C.-C. Lee, W.-C. Shyu, P.-N. Chong, and S.-Z. Lin
Hyperintense Putaminal Rim Sign Is Not a Hallmark of Multiple System Atrophy at 3T
AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2238 - 2242.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
F S Ertan, T Ertan, G Kiziltan, and H Uygucgil
Reliability and validity of the Geriatric Depression Scale in depression in Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1445 - 1447.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. M. Landau, K. C. Luk, M.-L. Jones, R. Siegrist-Johnstone, Y. K. Young, E. Kouassi, V. V. Rymar, A. Dagher, A. F. Sadikot, and J. Desbarats
Defective Fas expression exacerbates neurotoxicity in a model of Parkinson's disease
J. Exp. Med., September 6, 2005; 202(5): 575 - 581.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. A. Popat, S. K. Van Den Eeden, C. M. Tanner, V. McGuire, A. L. Bernstein, D. A. Bloch, A. Leimpeter, and L. M. Nelson
Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease
Neurology, August 9, 2005; 65(3): 383 - 390.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. Oba, A. Yagishita, H. Terada, A. J. Barkovich, K. Kutomi, T. Yamauchi, S. Furui, T. Shimizu, M. Uchigata, K. Matsumura, et al.
New and reliable MRI diagnosis for progressive supranuclear palsy
Neurology, June 28, 2005; 64(12): 2050 - 2055.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. M. Sturman, D. E. Vaillancourt, and D. M. Corcos
Effects of Aging on the Regularity of Physiological Tremor
J Neurophysiol, June 1, 2005; 93(6): 3064 - 3074.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
F. Stocchi, L. Vacca, S. Ruggieri, and C. W. Olanow
Intermittent vs Continuous Levodopa Administration in Patients With Advanced Parkinson Disease: A Clinical and Pharmacokinetic Study
Arch Neurol, June 1, 2005; 62(6): 905 - 910.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
G. Levy, E. D. Louis, L. Cote, M. Perez, H. Mejia-Santana, H. Andrews, J. Harris, C. Waters, B. Ford, S. Frucht, et al.
Contribution of Aging to the Severity of Different Motor Signs in Parkinson Disease
Arch Neurol, March 1, 2005; 62(3): 467 - 472.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
W. K. Scott, F. Zhang, J. M. Stajich, B. L. Scott, M. A. Stacy, and J. M. Vance
Family-based case-control study of cigarette smoking and Parkinson disease
Neurology, February 8, 2005; 64(3): 442 - 447.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. M. Sturman, D. E. Vaillancourt, L. V. Metman, R. A. E. Bakay, and D. M. Corcos
Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease
Brain, September 1, 2004; 127(9): 2131 - 2143.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Johnson, S. M. Hague, M. Hanson, A. Gibson, K. E. Wilson, E. W. Evans, A. A. Singleton, A. McInerney-Leo, R. L. Nussbaum, D. G. Hernandez, et al.
SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies
Neurology, August 10, 2004; 63(3): 554 - 556.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. W. Michell, S. J. G. Lewis, T. Foltynie, and R. A. Barker
Biomarkers and Parkinson's disease
Brain, August 1, 2004; 127(8): 1693 - 1705.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
G. Levy, E. D. Louis, H. Mejia-Santana, L. Cote, H. Andrews, J. Harris, C. Waters, B. Ford, S. Frucht, S. Fahn, et al.
Lack of Familial Aggregation of Parkinson Disease and Alzheimer Disease
Arch Neurol, July 1, 2004; 61(7): 1033 - 1039.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
Y. J. Li, M. A. Hauser, W. K. Scott, E. R. Martin, M. W. Booze, X. J. Qin, J. W. Walter, M. A. Nance, J. P. Hubble, W. C. Koller, et al.
Apolipoprotein E controls the risk and age at onset of Parkinson disease
Neurology, June 8, 2004; 62(11): 2005 - 2009.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. Thaisetthawatkul, B. F. Boeve, E. E. Benarroch, P. Sandroni, T. J. Ferman, R. Petersen, and P. A. Low
Autonomic dysfunction in dementia with Lewy bodies
Neurology, May 25, 2004; 62(10): 1804 - 1809.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Rajput, C. A. Robinson, and A. H. Rajput
Essential tremor course and disability: A clinicopathologic study of 20 cases
Neurology, March 23, 2004; 62(6): 932 - 936.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Herlofson, S. A. Lie, D. Arsland, and J. P. Larsen
Mortality and Parkinson disease: A community based study
Neurology, March 23, 2004; 62(6): 937 - 942.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Spanaki and A. Plaitakis
Bilineal transmission of Parkinson disease on Crete suggests a complex inheritance
Neurology, March 9, 2004; 62(5): 815 - 817.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
T. Foltynie, C. E. G. Brayne, T. W. Robbins, and R. A. Barker
The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study
Brain, March 1, 2004; 127(3): 550 - 560.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
S. Papapetropoulos, A. A. Argiriou, and J. Ellul
Clinical Characteristics of Late-Onset Parkinson Disease
Arch Neurol, December 1, 2003; 60(12): 1815 - 1816.
[Full Text] [PDF]


Home page
NeurologyHome page
E. D. Louis, G. Levy, H. Mejia-Santana, L. Cote, H. Andrews, J. Harris, C. Waters, B. Ford, S. Frucht, S. Fahn, et al.
Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD
Neurology, October 14, 2003; 61(7): 931 - 936.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Marder, G. Levy, E. D. Louis, H. Mejia-Santana, L. Cote, H. Andrews, J. Harris, C. Waters, B. Ford, S. Frucht, et al.
Accuracy of family history data on Parkinson's disease
Neurology, July 8, 2003; 61(1): 18 - 23.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K A Jellinger
How valid is the clinical diagnosis of Parkinson's disease in the community?
J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 1005 - 1006.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. K. Van Den Eeden, C. M. Tanner, A. L. Bernstein, R. D. Fross, A. Leimpeter, D. A. Bloch, and L. M. Nelson
Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity
Am. J. Epidemiol., June 1, 2003; 157(11): 1015 - 1022.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. Foroud, S.K. Uniacke, L. Liu, N. Pankratz, A. Rudolph, C. Halter, C. Shults, K. Marder, P.M. Conneally, W.C. Nichols, et al.
Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease
Neurology, March 11, 2003; 60(5): 796 - 801.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. Rao, L. Fisch, S. Srinivasan, F. D'Amico, T. Okada, C. Eaton, and C. Robbins
Does This Patient Have Parkinson Disease?
JAMA, January 15, 2003; 289(3): 347 - 353.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D E Riley and T C Chelimsky
Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, January 1, 2003; 74(1): 56 - 60.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. Levy, M.-X. Tang, E.D. Louis, L.J. Cote, B. Alfaro, H. Mejia, Y. Stern, and K. Marder
The association of incident dementia with mortality in PD
Neurology, December 10, 2002; 59(11): 1708 - 1713.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Schrag, Y Ben-Shlomo, and N Quinn
How valid is the clinical diagnosis of Parkinson's disease in the community?
J. Neurol. Neurosurg. Psychiatry, November 1, 2002; 73(5): 529 - 534.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
T Foltynie, S Sawcer, C Brayne, and R A Barker
The genetic basis of Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, October 1, 2002; 73(4): 363 - 370.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
C. W. Shults, D. Oakes, K. Kieburtz, M. F. Beal, R. Haas, S. Plumb, J. L. Juncos, J. Nutt, I. Shoulson, J. Carter, et al.
Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Arch Neurol, October 1, 2002; 59(10): 1541 - 1550.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
F. Stocchi, S. Ruggieri, L. Vacca, and C. W. Olanow
Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease
Brain, September 1, 2002; 125(9): 2058 - 2066.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
W C Nichols, N Pankratz, S K Uniacke, M W Pauciulo, C Halter, A Rudolph, P M Conneally, and T Foroud
Linkage stratification and mutation analysis at the parkin locus identifies mutation positive Parkinson's disease families
J. Med. Genet., July 1, 2002; 39(7): 489 - 492.
[Full Text] [PDF]


Home page
NeurologyHome page
K. Hedrich, K. Marder, J. Harris, M. Kann, T. Lynch, H. Meija-Santana, P. P. Pramstaller, E. Schwinger, S. B. Bressman, S. Fahn, et al.
Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations
Neurology, April 23, 2002; 58(8): 1239 - 1246.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
O. L. Lopez, J. T. Becker, D. I. Kaufer, R. L. Hamilton, R. A. Sweet, W. Klunk, and S. T. DeKosky
Research Evaluation and Prospective Diagnosis of Dementia With Lewy Bodies
Arch Neurol, January 1, 2002; 59(1): 43 - 46.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
W. K. Scott, M. A. Nance, R. L. Watts, J. P. Hubble, W. C. Koller, K. Lyons, R. Pahwa, M. B. Stern, A. Colcher, B. C. Hiner, et al.
Complete Genomic Screen in Parkinson Disease: Evidence for Multiple Genes
JAMA, November 14, 2001; 286(18): 2239 - 2244.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
E. R. Martin, W. K. Scott, M. A. Nance, R. L. Watts, J. P. Hubble, W. C. Koller, K. Lyons, R. Pahwa, M. B. Stern, A. Colcher, et al.
Association of Single-Nucleotide Polymorphisms of the Tau Gene With Late-Onset Parkinson Disease
JAMA, November 14, 2001; 286(18): 2245 - 2250.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. J. Hughes, S. E. Daniel, and A. J. Lees
Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease
Neurology, October 23, 2001; 57(8): 1497 - 1499.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
E. D. Louis, G. Levy, L. J. Cote, H. Mejia, S. Fahn, and K. Marder
Clinical Correlates of Action Tremor in Parkinson Disease
Arch Neurol, October 1, 2001; 58(10): 1630 - 1634.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. D. Abbott, H. Petrovitch, L. R. White, K. H. Masaki, C. M. Tanner, J. D. Curb, A. Grandinetti, P. L. Blanchette, J. S. Popper, and G. W. Ross
Frequency of bowel movements and the future risk of Parkinson's disease
Neurology, August 14, 2001; 57(3): 456 - 462.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. Warmuth-Metz, M. Naumann, I. Csoti, and L. Solymosi
Measurement of the Midbrain Diameter on Routine Magnetic Resonance Imaging: A Simple and Accurate Method of Differentiating Between Parkinson Disease and Progressive Supranuclear Palsy
Arch Neurol, July 1, 2001; 58(7): 1076 - 1079.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. W. Olanow, R. L. Watts, and W. C. Koller
An algorithm (decision tree) for the management of Parkinson's disease (2001):: Treatment
Neurology, June 12, 2001; 56(suppl_5): S1 - S88.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Holroyd, L Currie, and G F Wooten
Prospective study of hallucinations and delusions in Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, June 1, 2001; 70(6): 734 - 738.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G K Wenning, Y Ben-Shlomo, A Hughes, S E Daniel, A Lees, and N P Quinn
What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?
J. Neurol. Neurosurg. Psychiatry, April 1, 2000; 68(4): 434 - 440.
[Abstract] [Full Text] [PDF]